Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Receptors, Cholinergic"" wg kryterium: Temat


Tytuł:
Activation of M1 cholinergic receptors in mouse somatosensory cortex enhances information processing and detection behaviour.
Autorzy:
Mishra W; Eccles Institute of Neuroscience, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Kheradpezhouh E; Eccles Institute of Neuroscience, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Arabzadeh E; Eccles Institute of Neuroscience, John Curtin School of Medical Research, The Australian National University, Canberra, Australia. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Jan 02; Vol. 7 (1), pp. 3. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Cholinergic*
Somatosensory Cortex*/physiology
Animals ; Mice ; Acetylcholine ; Cognition ; Receptors, Muscarinic/metabolism
Czasopismo naukowe
Tytuł:
Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis.
Autorzy:
Jia D; Department of Neurology and Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin Medical University Tianjin, China.
Zhang F; Department of Neurology and Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin Medical University Tianjin, China.
Li H; Department of Neurology and Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin Medical University Tianjin, China.
Shen Y; Department of Neurology and Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin Medical University Tianjin, China.
Jin Z; Department of Neurology, Third Central Hospital of Tianjin, Tianjin, China.
Shi FD; Department of Neurology and Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin Medical University Tianjin, China.
Zhang C; Department of Neurology and Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin Medical University Tianjin, China.
Pokaż więcej
Źródło:
Aging and disease [Aging Dis] 2024 Apr 01; Vol. 15 (2), pp. 824-830. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Cholinergic*
Myasthenia Gravis*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Prednisone/therapeutic use ; Activities of Daily Living ; Prospective Studies
Czasopismo naukowe
Tytuł:
Starting eculizumab as rescue therapy in refractory myasthenic crisis.
Autorzy:
Vinciguerra C; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Largo Città di Ippocrate, 84100, Salerno, Italy. .
Bevilacqua L; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Largo Città di Ippocrate, 84100, Salerno, Italy.
Toriello A; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Largo Città di Ippocrate, 84100, Salerno, Italy.
Iovino A; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Largo Città di Ippocrate, 84100, Salerno, Italy.
Piscosquito G; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Largo Città di Ippocrate, 84100, Salerno, Italy.
Calicchio G; Anesthesia and Intensive Care Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
Barone P; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Largo Città di Ippocrate, 84100, Salerno, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Oct; Vol. 44 (10), pp. 3707-3709. Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Myasthenia Gravis*/immunology
Myasthenia Gravis*/therapy
Antibodies, Monoclonal, Humanized*/therapeutic use
Complement Inactivating Agents*/therapeutic use
Receptors, Cholinergic*/immunology
Humans ; Male ; Aged ; Autoantibodies/blood
Czasopismo naukowe
Tytuł:
Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography.
Autorzy:
Zhang JJ; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Jiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-Forest Biomass, Jiangsu Key Lab of Biomass-Based Green Fuels and Chemicals, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Fu H; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.; Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
Lin R; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Jiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-Forest Biomass, Jiangsu Key Lab of Biomass-Based Green Fuels and Chemicals, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Zhou J; Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
Haider A; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
Fang W; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Jiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-Forest Biomass, Jiangsu Key Lab of Biomass-Based Green Fuels and Chemicals, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Elghazawy NH; Department of Pharmaceutical, Chemistry, Faculty of Pharmacy & Biotechnology, German University in Cairo, 11835 Cairo, Egypt.
Rong J; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
Chen J; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
Li Y; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
Ran C; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02114, United States.
Collier TL; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
Chen Z; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Jiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-Forest Biomass, Jiangsu Key Lab of Biomass-Based Green Fuels and Chemicals, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.
Liang SH; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02114, United States.; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2023 Aug 24; Vol. 66 (16), pp. 10889-10916. Date of Electronic Publication: 2023 Aug 15.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Cholinergic*
Radiopharmaceuticals*/chemistry
Positron-Emission Tomography/methods ; Brain/diagnostic imaging ; Central Nervous System
Czasopismo naukowe
Tytuł:
Pregnancy in MuSK-positive myasthenia gravis: A single-center case series.
Autorzy:
Harada Y; Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
Bettin M; Division of Neurology, Centra Neurology, Lynchburg, Virginia, USA.
Juel VC; Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
Hobson-Webb LD; Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
Raja SM; Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
Sanders DB; Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
Massey JM; Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
Pokaż więcej
Źródło:
Muscle & nerve [Muscle Nerve] 2023 Jul; Vol. 68 (1), pp. 85-90. Date of Electronic Publication: 2023 May 07.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Cholinergic*
Myasthenia Gravis*/diagnosis
Humans ; Female ; Pregnancy ; Cesarean Section ; Retrospective Studies ; Autoantibodies
Czasopismo naukowe
Tytuł:
From phosphorylation to phenotype - Recent key findings on kinase regulation, downstream signaling and disease surrounding the receptor tyrosine kinase MuSK.
Autorzy:
Prömer J; Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Barresi C; Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Herbst R; Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. Electronic address: .
Pokaż więcej
Źródło:
Cellular signalling [Cell Signal] 2023 Apr; Vol. 104, pp. 110584. Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Neuromuscular Junction*/genetics
Neuromuscular Junction*/metabolism
Receptors, Cholinergic*/genetics
Receptors, Cholinergic*/metabolism
Phosphorylation ; LDL-Receptor Related Proteins/genetics ; Muscle Proteins/metabolism ; Receptor Protein-Tyrosine Kinases/metabolism
Czasopismo naukowe
Tytuł:
Impact on AChR open channel noise by pore-peripheral salt bridge depends on voltage and divalent cations.
Autorzy:
Strikwerda JR; Receptor Biology Laboratory, Department of Physiology and Biomedical Engineering, Rochester, Minnesota.
Natarajan K; Receptor Biology Laboratory, Department of Physiology and Biomedical Engineering, Rochester, Minnesota.
Sine SM; Receptor Biology Laboratory, Department of Physiology and Biomedical Engineering, Rochester, Minnesota; Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, Minnesota; Department of Neurology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota. Electronic address: .
Pokaż więcej
Źródło:
Biophysical journal [Biophys J] 2023 Jun 20; Vol. 122 (12), pp. 2430-2444. Date of Electronic Publication: 2023 Apr 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Receptors, Cholinergic*/genetics
Calcium*/metabolism
Cations, Divalent ; Membrane Potentials ; Muscles/metabolism ; Cations
Czasopismo naukowe
Tytuł:
Hypotonicity-Induced Increase in Duodenal Mucosal Permeability Is Regulated by Cholinergic Receptors in Rats.
Autorzy:
Dahlgren D; Department of Medical Cell Biology, Uppsala University, 751 23, Uppsala, Sweden. .
Nylander O; Department of Medical Cell Biology, Uppsala University, 751 23, Uppsala, Sweden.
Sjöblom M; Department of Medical Cell Biology, Uppsala University, 751 23, Uppsala, Sweden.
Pokaż więcej
Źródło:
Digestive diseases and sciences [Dig Dis Sci] 2023 May; Vol. 68 (5), pp. 1815-1823. Date of Electronic Publication: 2022 Nov 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Cholinergic*
Receptors, Nicotinic*
Rats ; Animals ; Tetrodotoxin/pharmacology ; Duodenum ; Permeability
Czasopismo naukowe
Tytuł:
Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis.
Autorzy:
Stascheit F; Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Chuquisana O; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Keller CW; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Ambrose PA; Department of Clinical Neurology, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
Hoffmann S; Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Gross CC; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Lehnerer S; Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Willcox N; Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Meisel A; Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Lünemann JD; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Pokaż więcej
Źródło:
European journal of neurology [Eur J Neurol] 2023 May; Vol. 30 (5), pp. 1409-1416. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Autoantibodies*/immunology
Complement Activation*/immunology
Myasthenia Gravis*/classification
Myasthenia Gravis*/drug therapy
Myasthenia Gravis*/immunology
Receptors, Cholinergic*/immunology
Humans ; Case-Control Studies ; Complement System Proteins/analysis ; Complement System Proteins/immunology ; Complement Pathway, Alternative ; Complement Pathway, Classical ; Male ; Female ; Young Adult ; Adult ; Middle Aged
Czasopismo naukowe
Tytuł:
Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes.
Autorzy:
Núñez-Carpintero I; Barcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, 08034, Barcelona, Spain.
Rigau M; Barcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, 08034, Barcelona, Spain.; MRC London Institute of Medical Sciences, Du Cane Road, London, W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
Bosio M; Barcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, 08034, Barcelona, Spain.; Coordination Unit Spanish National Bioinformatics Institute (INB/ELIXIR-ES), Barcelona Supercomputing Center, Barcelona, Spain.
O'Connor E; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.; Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada.
Spendiff S; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Azuma Y; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Pediatrics, Aichi Medical University, Nagakute, Japan.
Topf A; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Thompson R; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
't Hoen PAC; Center for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands.
Chamova T; Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, Alexandrovska University Hospital, Medical University-Sofia, Sofia, Bulgaria.
Tournev I; Department of Neurology, Expert Centre for Hereditary Neurologic and Metabolic Disorders, Alexandrovska University Hospital, Medical University-Sofia, Sofia, Bulgaria.; Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, 1618, Bulgaria.
Guergueltcheva V; Clinic of Neurology, University Hospital Sofiamed, Sofia University St. Kliment Ohridski, Sofia, Bulgaria.
Laurie S; Centro Nacional de Análisis Genómico (CNAG-CRG), Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Catalonia, Spain.
Beltran S; Centro Nacional de Análisis Genómico (CNAG-CRG), Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Catalonia, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona (UB), Barcelona, Spain.
Capella-Gutiérrez S; Barcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, 08034, Barcelona, Spain.; Coordination Unit Spanish National Bioinformatics Institute (INB/ELIXIR-ES), Barcelona Supercomputing Center, Barcelona, Spain.
Cirillo D; Barcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, 08034, Barcelona, Spain. .
Lochmüller H; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.; Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada.; Centro Nacional de Análisis Genómico (CNAG-CRG), Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Catalonia, Spain.; Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.; Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Valencia A; Barcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, 08034, Barcelona, Spain.; Coordination Unit Spanish National Bioinformatics Institute (INB/ELIXIR-ES), Barcelona Supercomputing Center, Barcelona, Spain.; ICREA, Pg. Lluís Companys 23, 08010, Barcelona, Spain.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Feb 28; Vol. 15 (1), pp. 1227. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Myasthenic Syndromes, Congenital*/genetics
Myasthenic Syndromes, Congenital*/diagnosis
Humans ; Neuromuscular Junction/metabolism ; Rare Diseases/metabolism ; Workflow ; Receptors, Cholinergic/genetics ; Receptors, Cholinergic/metabolism ; Mutation
Czasopismo naukowe
Tytuł:
The YAP1/TAZ-TEAD transcriptional network regulates gene expression at neuromuscular junctions in skeletal muscle fibers.
Autorzy:
Gessler L; Institute of Biochemistry, Medical Faculty, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Huraskin D; Institute of Biochemistry, Medical Faculty, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Jian Y; Institute of Biochemistry, Medical Faculty, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Eiber N; Institute of Biochemistry, Medical Faculty, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Hu Z; Nephrology Division, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Prószyński TJ; Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wrocław, Poland.
Hashemolhosseini S; Institute of Biochemistry, Medical Faculty, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany.; Muscle Research Center, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Nucleic acids research [Nucleic Acids Res] 2024 Jan 25; Vol. 52 (2), pp. 600-624.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Regulatory Networks*
Transcription Factors*/genetics
Transcription Factors*/metabolism
Mice ; Animals ; Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Muscle Fibers, Skeletal/metabolism ; Neuromuscular Junction/metabolism ; Mice, Knockout ; Gene Expression ; Receptors, Cholinergic/genetics ; Receptors, Cholinergic/metabolism ; Muscle, Skeletal/metabolism
Czasopismo naukowe
Tytuł:
Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis.
Autorzy:
Fu Y; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, 87 Dingjiaqiao Road, 210009, Nanjing, China.
Shen K; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Wang H; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Wang S; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Wang X; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Zhu L; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Zheng Y; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Zou T; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Ci H; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Dong Q; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China. .; Key Laboratory of Whole-period Monitoring and Precise Intervention of Digestive Cancer, Shanghai Municipal Health Commission, Minhang Hospital, Fudan University, Shanghai, China. .
Qin LX; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China. .; Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China. .
Pokaż więcej
Źródło:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Mar 08; Vol. 9 (1), pp. 63. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Cholangiocarcinoma*/drug therapy
Cholangiocarcinoma*/genetics
Bile Duct Neoplasms*/drug therapy
Bile Duct Neoplasms*/genetics
Bile Duct Neoplasms*/metabolism
Benzenesulfonamides*
Benzylamines*
Humans ; beta Catenin/metabolism ; Brain-Derived Neurotrophic Factor/genetics ; Nicotine ; Acetylcholine ; Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics ; Gemcitabine ; Glycogen Synthase Kinase 3 beta ; Cell Line, Tumor ; Bile Ducts, Intrahepatic/metabolism ; Bile Ducts, Intrahepatic/pathology ; Neurotransmitter Agents ; Receptors, Cholinergic ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Comparison of three methods for the detection of antibodies against muscle-specific kinase.
Autorzy:
Luong K; ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA.
Lozier BK; ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA.
Novis CL; ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA.
Smith TL; ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA; Department of Pathology, University of Utah School of Medicine, 15 N Medical Dr. East Ste. 1100, Salt Lake City, UT 84112, USA; Geriatric Research Education and Clinical Center, George E. Whalen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA; Department of Neurology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA; Neurology Service, George E. Whalen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.
Zuromski LM; ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA.
Peterson LK; ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA; Department of Pathology, University of Utah School of Medicine, 15 N Medical Dr. East Ste. 1100, Salt Lake City, UT 84112, USA. Electronic address: .
Pokaż więcej
Źródło:
Journal of immunological methods [J Immunol Methods] 2024 Mar; Vol. 526, pp. 113627. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Myasthenia Gravis*
Humans ; Receptors, Cholinergic ; Receptor Protein-Tyrosine Kinases ; Autoantibodies ; Enzyme-Linked Immunosorbent Assay ; Antibodies, Monoclonal, Humanized ; Immunoglobulin G ; Muscles
Czasopismo naukowe
Tytuł:
Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungs.
Autorzy:
Hayashi R; Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz; Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
Srisomboon Y; Department of Animal Science, University of Minnesota, St Paul, Minn; Department of Integrative Biology and Physiology, University of Minnesota, St Paul, Minn.
Iijima K; Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz; Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
Maniak PJ; Department of Animal Science, University of Minnesota, St Paul, Minn; Department of Integrative Biology and Physiology, University of Minnesota, St Paul, Minn.
Tei R; Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz; Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
Kobayashi T; Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz; Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
Matsunaga M; Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz; Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
Luo H; Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz; Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
Masuda MY; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minn; Mayo Clinic Graduate School of Biomedical Sciences, Scottsdale, Ariz.
O'Grady SM; Department of Animal Science, University of Minnesota, St Paul, Minn; Department of Integrative Biology and Physiology, University of Minnesota, St Paul, Minn.
Kita H; Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz; Department of Medicine, Mayo Clinic, Scottsdale, Ariz; Department of Immunology, Mayo Clinic Rochester, Rochester, Minn; Department of Immunology, Mayo Clinic Arizona, Scottsdale, Ariz. Electronic address: .
Pokaż więcej
Źródło:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Mar; Vol. 153 (3), pp. 793-808.e2. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Interleukin-33*/metabolism
Asthma*
Mice ; Animals ; Humans ; Mice, Knockout ; Lung ; Epithelium ; Acetylcholine ; Allergens ; Cholinergic Agents ; Receptors, Cholinergic/metabolism
Czasopismo naukowe
Tytuł:
Efgartigimod improves triple-negative myasthenia gravis.
Autorzy:
Frangiamore R; Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy.
Rinaldi E; Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy.
Vanoli F; Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy.; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Andreetta F; Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy.
Mantegazza R; Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy.
Antozzi C; Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy. .; Immunotherapy and Apheresis Departmental Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Mar; Vol. 45 (3), pp. 1307-1309. Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:
Letter
MeSH Terms:
Myasthenia Gravis*/drug therapy
Humans ; Receptors, Cholinergic ; Autoantibodies
Opinia redakcyjna
Tytuł:
Rethinking the diagnosis of double-seronegative myasthenia gravis.
Autorzy:
Kim S; Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
Eun MY; Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Lee JJ; Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
Seok HY; Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
Pokaż więcej
Źródło:
European journal of neurology [Eur J Neurol] 2024 Mar; Vol. 31 (3), pp. e16151. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Letter
MeSH Terms:
Myasthenia Gravis*/diagnosis
Humans ; Receptors, Cholinergic ; Autoantibodies
Opinia redakcyjna
Tytuł:
Reply to letter in response to Rethinking the diagnosis of double-seronegative myasthenia gravis.
Autorzy:
Martinez-Harms R; Ellen & Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, Toronto, Ontario, Canada.; University Health Network, University of Toronto, Toronto, Ontario, Canada.
Barnett C; Ellen & Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, Toronto, Ontario, Canada.; University Health Network, University of Toronto, Toronto, Ontario, Canada.
Alcantara M; Ellen & Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, Toronto, Ontario, Canada.; University Health Network, University of Toronto, Toronto, Ontario, Canada.
Bril V; Ellen & Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, Toronto, Ontario, Canada.; University Health Network, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
European journal of neurology [Eur J Neurol] 2024 Mar; Vol. 31 (3), pp. e16152. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Letter
MeSH Terms:
Myasthenia Gravis*/diagnosis
Humans ; Receptors, Cholinergic
Opinia redakcyjna
Tytuł:
A release of local subunit conformational heterogeneity underlies gating in a muscle nicotinic acetylcholine receptor.
Autorzy:
Thompson MJ; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
Mansoub Bekarkhanechi F; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
Ananchenko A; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
Nury H; Université Grenoble Alpes, CNRS, CEA, IBS, F-38000, Grenoble, France.
Baenziger JE; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Feb 27; Vol. 15 (1), pp. 1803. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Nicotinic*/genetics
Receptors, Nicotinic*/metabolism
Ion Channel Gating/physiology ; Molecular Conformation ; Receptors, Cholinergic/metabolism ; Muscles/metabolism
Czasopismo naukowe
Tytuł:
Serum immunoglobulin G level reduction is a predictor of short-term improvement in patients with myasthenia gravis undergoing plasmapheresis.
Autorzy:
Konno S; Department of Neurology, Toho University Ohashi Medical Center, Tokyo, Japan.
Fujioka T; Department of Neurology, Toho University Ohashi Medical Center, Tokyo, Japan.
Pokaż więcej
Źródło:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2024 Feb; Vol. 28 (1), pp. 131-140. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:
Journal Article
MeSH Terms:
Myasthenia Gravis*
Humans ; Receptors, Cholinergic ; Plasmapheresis ; Autoantibodies ; Immunoglobulin G
Czasopismo naukowe
Tytuł:
Acetylcholine receptor based chemogenetics engineered for neuronal inhibition and seizure control assessed in mice.
Autorzy:
Nguyen QA; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA. .
Klein PM; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA. .
Xie C; CODA Biotherapeutics, 240 East Grand Ave., South San Francisco, CA, 94080, USA.
Benthall KN; CODA Biotherapeutics, 240 East Grand Ave., South San Francisco, CA, 94080, USA.
Iafrati J; CODA Biotherapeutics, 240 East Grand Ave., South San Francisco, CA, 94080, USA.
Homidan J; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA.
Bendor JT; CODA Biotherapeutics, 240 East Grand Ave., South San Francisco, CA, 94080, USA.
Dudok B; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA.; Department of Neurology, Baylor College of Medicine, Houston, TX, 77030, USA.
Farrell JS; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA.
Gschwind T; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA.
Porter CL; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA.
Keravala A; CODA Biotherapeutics, 240 East Grand Ave., South San Francisco, CA, 94080, USA.
Dodson GS; CODA Biotherapeutics, 240 East Grand Ave., South San Francisco, CA, 94080, USA.
Soltesz I; Department of Neurosurgery, Stanford University, Stanford, CA, 94305, USA.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Jan 18; Vol. 15 (1), pp. 601. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Nicotinic*/genetics
Epilepsy*
Mice ; Male ; Humans ; Animals ; Receptors, Cholinergic ; alpha7 Nicotinic Acetylcholine Receptor/genetics ; Nicotinic Agonists/pharmacology ; Acetylcholine/pharmacology ; Seizures/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies